Literature DB >> 18467591

Discovery of a cytokine and its receptor by functional screening of the extracellular proteome.

Haishan Lin1, Ernestine Lee, Kevin Hestir, Cindy Leo, Minmei Huang, Elizabeth Bosch, Robert Halenbeck, Ge Wu, Aileen Zhou, Dirk Behrens, Diane Hollenbaugh, Thomas Linnemann, Minmin Qin, Justin Wong, Keting Chu, Stephen K Doberstein, Lewis T Williams.   

Abstract

To understand the system of secreted proteins and receptors involved in cell-cell signaling, we produced a comprehensive set of recombinant secreted proteins and the extracellular domains of transmembrane proteins, which constitute most of the protein components of the extracellular space. Each protein was tested in a suite of assays that measured metabolic, growth, or transcriptional responses in diverse cell types. The pattern of responses across assays was analyzed for the degree of functional selectivity of each protein. One of the highly selective proteins was a previously undescribed ligand, designated interleukin-34 (IL-34), which stimulates monocyte viability but does not affect responses in a wide spectrum of other assays. In a separate functional screen, we used a collection of extracellular domains of transmembrane proteins to discover the receptor for IL-34, which was a known cytokine receptor, colony-stimulating factor 1 (also called macrophage colony-stimulating factor) receptor. This systematic approach is thus useful for discovering new ligands and receptors and assessing the functional selectivity of extracellular regulatory proteins.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18467591     DOI: 10.1126/science.1154370

Source DB:  PubMed          Journal:  Science        ISSN: 0036-8075            Impact factor:   47.728


  276 in total

Review 1.  Transcriptional programming of the dendritic cell network.

Authors:  Gabrielle T Belz; Stephen L Nutt
Journal:  Nat Rev Immunol       Date:  2012-01-25       Impact factor: 53.106

2.  Microglial pilgrimage to the brain.

Authors: 
Journal:  Nat Med       Date:  2010-12       Impact factor: 53.440

3.  IL-34 is a tissue-restricted ligand of CSF1R required for the development of Langerhans cells and microglia.

Authors:  Yaming Wang; Kristy J Szretter; William Vermi; Susan Gilfillan; Cristina Rossini; Marina Cella; Alexander D Barrow; Michael S Diamond; Marco Colonna
Journal:  Nat Immunol       Date:  2012-06-24       Impact factor: 25.606

4.  Functional overlap but differential expression of CSF-1 and IL-34 in their CSF-1 receptor-mediated regulation of myeloid cells.

Authors:  Suwen Wei; Sayan Nandi; Violeta Chitu; Yee-Guide Yeung; Wenfeng Yu; Minmei Huang; Lewis T Williams; Haishan Lin; E Richard Stanley
Journal:  J Leukoc Biol       Date:  2010-05-26       Impact factor: 4.962

5.  A potential osteoporosis target in the FAS ligand/FAS pathway of osteoblast to osteoclast signaling.

Authors:  Daniel R Jones
Journal:  Ann Transl Med       Date:  2015-08

6.  Transplant tolerance: a new role for IL-34.

Authors:  James I Kim; Laurence A Turka
Journal:  J Clin Invest       Date:  2015-09-21       Impact factor: 14.808

7.  IL-34 is a Treg-specific cytokine and mediates transplant tolerance.

Authors:  Séverine Bézie; Elodie Picarda; Jason Ossart; Laurent Tesson; Claire Usal; Karine Renaudin; Ignacio Anegon; Carole Guillonneau
Journal:  J Clin Invest       Date:  2015-09-21       Impact factor: 14.808

8.  Phenotypic characterization of a Csf1r haploinsufficient mouse model of adult-onset leukodystrophy with axonal spheroids and pigmented glia (ALSP).

Authors:  Violeta Chitu; Solen Gokhan; Maria Gulinello; Craig A Branch; Madhuvati Patil; Ranu Basu; Corrina Stoddart; Mark F Mehler; E Richard Stanley
Journal:  Neurobiol Dis       Date:  2014-12-09       Impact factor: 5.996

9.  Design and pharmacology of a highly specific dual FMS and KIT kinase inhibitor.

Authors:  Chao Zhang; Prabha N Ibrahim; Jiazhong Zhang; Elizabeth A Burton; Gaston Habets; Ying Zhang; Ben Powell; Brian L West; Bernice Matusow; Garson Tsang; Rafe Shellooe; Heidi Carias; Hoa Nguyen; Adhirai Marimuthu; Kam Y J Zhang; Angela Oh; Ryan Bremer; Clarence R Hurt; Dean R Artis; Guoxian Wu; Marika Nespi; Wayne Spevak; Paul Lin; Keith Nolop; Peter Hirth; Greg H Tesch; Gideon Bollag
Journal:  Proc Natl Acad Sci U S A       Date:  2013-03-14       Impact factor: 11.205

10.  Loss of IL-34 Expression Indicates Poor Prognosis in Patients With Lung Adenocarcinoma.

Authors:  Zhendong Wang; Jun Zhu; Tianyi Wang; Hao Zhou; Jinjie Wang; Zhanghao Huang; Haijian Zhang; Jiahai Shi
Journal:  Front Oncol       Date:  2021-07-16       Impact factor: 6.244

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.